High Purity Pharmaceutical Grade 877399-52-5 Crizotinib for Anti-cancer Treatment
Zogulitsadzina | Crizotinib |
Mawu ofanana ndi mawu | PF-02341066;3- [(1R)-1- (2,6-Dichloro-3-fluorophenyl) ethoxy]-5- [1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;Mtengo wa 2341066 |
CAS No. | 877399-52-5 |
Maonekedwe | Ufa wa crystalline woyera mpaka woyera |
Molecular Formula | C21H22Cl2FN5O |
Kulemera kwa Maselo | 450.34 |
Kugwiritsa ntchito | Gulu la Mankhwala kapena Cholinga cha Kafukufuku |
Kulongedza | Monga mwa pempho lanu |
Kusungirako | Sungani m'zotengera zolimba, zosagwira kuwala pamalo ozizira |
CrizotinibCas: 877399-52-5 | ||
Zinthu | Zofotokozera | Zotsatira |
Maonekedwe | Ufa wa crystalline woyera mpaka woyera | White crystalline ufa |
Chizindikiritso | H-NMR, MS | Zimagwirizana |
Zosungunulira Zotsalira | isopropanol ≤0.5% EtOAc≤0.5% THF≤0.072% n-Heptane≤0.5% Toluene≤0.5% | 0.3% ND ND ND ND ND |
Zitsulo Zolemera | ≤10ppm | Zimagwirizana |
Zomwe zili m'madzi | £0.5% | 0.3% |
Zotsalira pakuyatsa | £0.5% | 0.05% |
Enantiomer | £0.1% | <LOQ |
Zoyipa Zogwirizana ndi HPLC | Chidetso chimodzi≤0.1% Chidetso chonse ≤1.0% | 0.05% 0.12% |
Purity (HPLC) | ³99.0% | 99.88% |
Zambiri Zamakampani
√ Kudziwa kwathunthu kwa Management layer mu otsatira fakitale ndi akatswiri aluso; √ Quality nthawi zonse timaganizira kwambiri, Olimba QC dongosolo; √ zaka 11 zokumana nazo zogulitsa kunja; √ Independent R&D labu; √ Misonkhano iwiri yosayinidwa yanthawi yayitali ya GMP; √ Zida zolemera zamafakitale ambiri opanda pake pazosintha makonda; √ Gulu logwira ntchito molimbika kwambiri lomwe lili ndi njira yosasinthika.Lembani uthenga wanu apa ndikutumiza kwa ife